zinc protoporphyrin ix has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bil, J; Bugajski, M; Dulak, J; Golab, J; Issat, T; Jozkowicz, A; Nowis, D; Salwa, P; Stoklosa, T; Szokalska, A; Was, H; Winiarska, M | 1 |
1 other study(ies) available for zinc protoporphyrin ix and B16 Melanoma
Article | Year |
---|---|
Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cytostatic Agents; Enzyme Inhibitors; Female; Heme Oxygenase-1; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Protoporphyrins; RNA, Small Interfering; Transfection | 2008 |